MedTrace Logo

CardioMEMS European Monitoring Study for Heart Failure

NCT02693691 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 239

Last updated 2022-04-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to characterize the use of the CardioMEMS™ HF System when used in a real-world setting.

Conditions

Interventions

DEVICE

CardioMEMS HF System

Pulmonary Artery Pressure Monitoring

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Christiane Angermann, Prof. Dr. · Deutsches Zentrum für Herzinsuffizienz Würzburg

  • Michael Boehm, Prof. Dr. · University Hospital, Saarland

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-03-31
Completion
2020-03-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693691 on ClinicalTrials.gov